Filing Details
- Accession Number:
- 0001140361-10-034940
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-25 13:52:08
- Reporting Period:
- 2010-05-27
- Filing Date:
- 2010-08-25
- Accepted Time:
- 2010-08-25 13:52:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380186 | Kyle Keese | 2273 Research Blvd. Suite 400 Rockville MD 20850 | Svp, Mfg Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-05-27 | 5,276 | $0.00 | 14,346 | No | 4 | J | Direct | |
| Common Stock | Disposition | 2010-08-18 | 5,276 | $17.50 | 9,070 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | J | Direct | |
| No | 4 | S | Direct |
Footnotes
- In-kind pro rata distribution from BioPharm, L.L.C., of which the reporting person is a non-managing member, for no consideration.
Billionaire Hedge Funds
